- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06482424
The Effect of Aromatherapy on Sleep, Anxiety and Vital Signs in Those With Essential Hypertension (Hypertension) (hypertension)
The Effect of Aromatherapy on Sleep, Anxiety and Vital Signs in Those With Essential Hypertension
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
METHOD OF THE THESIS:
PURPOSE AND TYPE OF RESEARCH This study will be conducted as a randomized controlled experimental study to determine the effect of aromatherapy on sleep, anxiety and vital signs in individuals with essential hypertension.
HYPOTHESES H01: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has no effect on systolic blood pressure in patients with Essential Hypertension.
H11: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has an effect on systolic blood pressure in patients with Essential Hypertension.
H02: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has no effect on diastolic blood pressure in patients with Essential Hypertension.
H12: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has an effect on diastolic blood pressure in patients with Essential Hypertension.
H03: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has no effect on pulse rate in patients with Essential Hypertension.
H13: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has an effect on pulse rate in patients with Essential Hypertension.
H04: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has no effect on anxiety level in patients with Essential Hypertension.
H14: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has an effect on the anxiety level in patients with Essential Hypertension.
H05: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has no effect on sleep level in patients with Essential Hypertension.
H15: Lavender oil applied by inhalation for 5 minutes twice a day for 4 weeks has an effect on sleep level in patients with Essential Hypertension.
ETHICAL ASPECTS OF RESEARCH In order to conduct the research, Erciyes University Faculty of Health Sciences Department of Nursing Academic Board Decision, Niğde Bor State Hospital Institutional Permission and TR Ministry of Health Kayseri City Hospital GETAT Clinical Research Ethics Committee Approval will be obtained. The purpose of the research will be explained to the individuals participating in the research and written voluntary consent will be obtained.
PLACE AND TIME WHERE THE RESEARCH WILL BE CONDUCTED will be collected from patients treated at the internal medicine outpatient clinic of Niğde Bor State Hospital between 15.05-2024-31.12.2024 . Bor State Hospital has a capacity of 100 beds and employs 407 personnel. Bor State Hospital offers internal medicine, cardiology, gynecology, ophthalmology, orthopedics, general surgery, child health and diseases, skin and venereal diseases, anesthesiology and reanimation, psychiatry, infection , urology outpatient clinic service and general surgery, internal medicine, urology, orthopedics, women. Obstetrics, ophthalmology, internal medicine, infection, cardiology, child health and diseases, skin and venereal diseases, general intensive care, neonatal intensive care clinic services are provided. In the Bor State Hospital internal medicine outpatient clinic, patients who are not compliant with treatment and have a lack of knowledge are given training by a training nurse upon the request of a doctor. Drug treatment is administered to patients diagnosed with hypertension in the internal medicine outpatient clinic.
UNIVERSE AND SAMPLING OF THE RESEARCH consists of patients who were treated in the internal medicine outpatient clinic at Niğde Bor State Hospital between January 2022 and December 2022 . It was planned to include at least 20 people with essential hypertension in the intervention group and at least 20 people in the placebo group in the study sample. Groups will be selected according to similar characteristics in terms of variables such as gender, age the contact information of the patients who voluntarily participate in the study and meet the study conditions . After visiting the patients at home, the patient's allergy status will be observed by applying oil to the patient's wrist one day before starting aromatherapy . Patients without allergies will be evaluated in terms of the inclusion criteria and the study will be conducted with patients who meet the criteria.
COLLECTION OF DATA Actions to be taken to the Intervention Group Before the research, patients will be informed about the purpose and method of the study and then their approval will be obtained through an informed consent form. A personal information form will be filled out by the researcher for the patients in the intervention group, and an individual in-depth interview will be conducted with the questions in the oil application patient opinions form. The researcher will measure the temperature, respiratory rate, saturation level, blood pressure and pulse of the patients in the intervention group at their homes and will record them in the patient follow-up chart-researcher form. In the following days, patients will be called by phone and reminded to measure their blood pressure and pulse with a semi-automatic blood pressure monitor and record it on the patient follow-up chart-researcher form. In line with the lavender oil application protocol, patients in the intervention group will drop medical lavender oil on gauze and smell it for 5 minutes every morning and evening for 4 weeks. The patient will be instructed and reminded to record his/her blood pressure and pulse rate on the patient monitoring chart-researcher form five days a week, half an hour before and after aromatherapy in the morning and evening for 4 weeks.
The state-trait anxiety scale and Pittsburg Sleep Quality Index score will be recorded on the patient follow-up chart-researcher form by the researcher at the patient's home at the beginning of the first week and at the end of the fourth week. The aromatic oil given to patients in the intervention group will be placed in 10ml dark glass bottles with droppers and a numbered label will be attached to the bottle.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Niğde
-
Merkez, Niğde, Turkey, 51200
- Niğde Bor Devlet Hastanesi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Research Inclusion Criteria
- Those aged between 18-65,
- Understands Turkish, has good cognitive functions and can communicate,
- Followed with the diagnosis of essential hypertension for at least 1 year,
- Those receiving antihypertensive medical drug treatment, - There has been no change in antihypertensive drug treatment for the last 1 month,
- Do not have a chronic respiratory system disease (such as Asthma, COPD), which is important for the effectiveness of aromatherapy,
- Non-pregnant,
- Not receiving anxiolytic or hypnotic treatment for at least 6 months,
- Regularly measures blood pressure at home with its own semi-automatic blood pressure monitor on the upper arm,
- Not having any psychiatric diagnosis,
- Patients who agree to participate in the study will be included in the study.
Criteria for Exclusion from the Study
- Those under the age of 18 and over the age of 65,
- Having difficulty in applying and understanding the treatment protocol,
- Having a psychiatric disease that impairs cognitive functions, such as bipolar disorder or schizophrenia,
- Having any respiratory system disease,
- Those who are allergic to or sensitive to the scent of lavender oil,
- Those who are in the process of trying antihypertensive treatment,
- Cancer patients and those under follow-up,
- Those who have a condition that prevents them from smelling,
- Uses other integrative health practices in the treatment process,
- Patients who do not agree to participate in the study will not be included
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intervention group
Actions to be taken to the Intervention Group The state-trait anxiety scale and Pittsburg Sleep Quality Index score will be recorded on the patient follow-up chart-researcher form by the researcher at the patient's home at the beginning of the first week and at the end of the fourth week.
The aromatic oil given to patients in the intervention group will be placed in 10ml dark glass bottles with droppers and a numbered label will be attached to the bottle.
|
Actions to be taken to the Intervention Group The researcher will record the state-trait anxiety scale and Pittsburg Sleep Quality Index score on the patient follow-up chart-researcher form at the patient's home at the beginning of the first week and at the end of the fourth week. The aromatic oil given to patients in the intervention group will be placed in 10ml dark glass bottles with droppers and a numbered label will be attached to the bottle. Procedures to be Performed on the Placebo Group The researcher will record the state-trait anxiety scale and Pittsburg Sleep Quality Index score on the patient follow-up chart-researcher form at the patient's home at the beginning of the first week and at the end of the fourth week. Sesame oil given to patients in the placebo group will be placed in 10 ml dark glass bottles with droppers and a number two label will be attached to the bottle.
Other Names:
|
|
Experimental: placebo group
Procedures to be Performed on the Placebo Group The researcher will record the state-trait anxiety scale and Pittsburg Sleep Quality Index score on the patient follow-up chart-researcher form at the patient's home at the beginning of the first week and at the end of the fourth week.
Sesame oil given to patients in the placebo group will be placed in 10 ml dark glass bottles with droppers and a label with number two will be attached to the bottle.
|
Actions to be taken to the Intervention Group The researcher will record the state-trait anxiety scale and Pittsburg Sleep Quality Index score on the patient follow-up chart-researcher form at the patient's home at the beginning of the first week and at the end of the fourth week. The aromatic oil given to patients in the intervention group will be placed in 10ml dark glass bottles with droppers and a numbered label will be attached to the bottle. Procedures to be Performed on the Placebo Group The researcher will record the state-trait anxiety scale and Pittsburg Sleep Quality Index score on the patient follow-up chart-researcher form at the patient's home at the beginning of the first week and at the end of the fourth week. Sesame oil given to patients in the placebo group will be placed in 10 ml dark glass bottles with droppers and a number two label will be attached to the bottle.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Effect of Aromatherapy on Sleep, Anxiety and Vital Signs in Individuals with Essential Hypertension
Time Frame: 1 yıl
|
In this study, the effect of lavender aromatic oil on sleep, anxiety and vital signs in individuals with essential hypertension will be evaluated.
In the study, patients will be administered lavender oil by inhalation for 5 minutes twice a day for 4 weeks.
Medicinal lavender oil will be applied to the intervention group, and sesame oil will be applied to the placebo group.
|
1 yıl
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: esra doğan, esramercan11021985@gmail.com.tr
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10636659
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on intervention group
-
Muğla Sıtkı Koçman UniversityNot yet recruiting
-
University of LiegeCentre Hospitalier Universitaire de Liege; Bial Foundation; FNRS (Télévie); Fondation...Active, not recruitingPain | Cancer | Fatigue | Cognitive Impairment | Sleep Disturbance | Distress, EmotionalBelgium
-
Beijing HospitalThe First Hospital of Jilin University; Jilin University; Chinese Academy of...Not yet recruitingAsthma | Allergic Disease
-
Hospital de Clinicas de Porto AlegreUnknown
-
University of California, San FranciscoNational Cancer Institute (NCI); Cancer Prevention Institute of CaliforniaCompletedHereditary Breast and Ovarian Cancer Syndrome
-
University of Sao PauloCompletedAnxiety | Self Esteem
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Salubris (Suzhou) Pharmaceutical Co., Ltd.RecruitingPostmenopausal Women With OsteoporosisChina
-
Haute Ecole de Santé VaudCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipSwitzerland
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases
-
University of OxfordOxford Brookes UniversityRecruitingOverweight/Obesity, AdolescentUnited Kingdom